Abbott LaboratoriesABTNYSE
Loading
Income Before Tax Over TimeExpanding
Percentile Rank100
3Y CAGR+0.6%
5Y CAGR+11.2%
Year-over-Year Change
Pre-tax earnings
3Y CAGR
+0.6%/yr
vs +30.4%/yr prior
5Y CAGR
+11.2%/yr
Recent deceleration
Acceleration
-29.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $8.47B | +20.7% |
| 2024 | $7.01B | +5.2% |
| 2023 | $6.66B | -19.8% |
| 2022 | $8.31B | +1.2% |
| 2021 | $8.21B | +65.3% |
| 2020 | $4.97B | +21.9% |
| 2019 | $4.08B | +41.9% |
| 2018 | $2.87B | +28.8% |
| 2017 | $2.23B | +57.9% |
| 2016 | $1.41B | - |